Publications by authors named "Christopher P Hebbes"

Claim this Profile
I
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells.
Mark F Bird, Christopher P Hebbes, Anushuya Tamang, Jonathon Mark Willets, Jonathan P Thompson

Br J Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
Zoë L S Brookes, Emily N Stedman, Nicola J Brown, Christopher P Hebbes, Remo Guerrini

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
Raffaella Vergura, Elena Valenti, Christopher P Hebbes, Elaine C Gavioli, Barbara Spagnolo

Peptides· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
Giacomo Carrà, Anna Rizzi, Remo Guerrini, Timothy A Barnes, John McDonald, Christopher P Hebbes

J Pharmacol Exp Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis